TIRZ

Description

What it is

TIRZ is a synthetic peptide that acts as an agonist at both the glucose-dependent insulinotropic polypeptide (GIP) receptor and the glucagon-like peptide-1 (GLP-1) receptor. This dual activity sits between single-receptor agonists such as SEMA and triple agonists such as R3TA.

Research context

Used in metabolic and endocrine research to study combined incretin receptor activity and to compare signalling profiles across the agonist family.

Handling

Supplied lyophilised in a sealed 3 mL vial. Store sealed vials refrigerated and protected from light. Reconstitute with an appropriate sterile diluent immediately before use and keep reconstituted material cold. Avoid repeated freeze–thaw cycles.

Research use only. Not for human or veterinary use, and not for diagnostic or therapeutic application.